Eli Lilly & Co. shares fell as much as 3% after Sen. Bernie Sanders tweeted about the company’s Lantus insulin drug. Sanders said “it makes no sense that the same drug that costs $70 in France costs $450 in the US. We should reduce barriers to importation of drugs.” The stock recovered afterwards, and was down 1.6% in afternoon trade, about the same as before the Sanders missive.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News